Search - tctmd.com

Displaying 761 - 777 of 777

Sort: Relevancy | Date

Presentation TCT 2012

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

Presenter: Peter Neuzil

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Niccoli Giampaolo

October 22, 2012

$PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension$

Presentation TCT 2012

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Presenter: Shao Liang Chen

October 22, 2012

Presentation

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Presenter: B.P. Geisler

September 12, 2012

Presentation

Significant Reduction in Systolic BP Following Renal Artery Stenting in Patients with Uncontrolled Hypertension

Presenter: Michael R. Jaff

September 07, 2012

$Renal Denervation for treatment of refractory hypertension: is it really a cure?$

Presentation ACVS 2012

Renal Denervation for treatment of refractory hypertension: is it really a cure?

Presenter: A. Sreenivas Kumar

August 03, 2012

Presentation Fellows 2012

Renal Artery Stenosis and Renovascular Hypertension

Presenter: Deepak Bhatt

April 22, 2012

Presentation GI2 2012

Rationale and Background to Treat Resistant Hypertension with Renal Denervation

Presenter: Martin B. Leon

April 13, 2012

Presentation GI2 2012

New devices for heart failure and pulmonary hypertension

Presenter: Saibal Kar

April 12, 2012

Presentation ACC 2012

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

Presenter: Murray Esler

March 25, 2012

Presentation

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Presenter: Mitsuyasu Terashima

February 29, 2012

Presentation

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Presenter: M. Brandt

February 26, 2012

Advertisement

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Hypertension: Renal Denervation

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Significant Reduction in Systolic BP Following Renal Artery Stenting in Patients with Uncontrolled Hypertension

Renal Denervation for treatment of refractory hypertension: is it really a cure?

Renal Artery Stenosis and Renovascular Hypertension

Rationale and Background to Treat Resistant Hypertension with Renal Denervation

New devices for heart failure and pulmonary hypertension

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content